{"id":47923,"date":"2022-09-01T22:01:39","date_gmt":"2022-09-01T20:01:39","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/arcturus-therapeutics-to-attend-the-following-investor-conferences\/"},"modified":"2022-09-01T22:01:39","modified_gmt":"2022-09-01T20:01:39","slug":"arcturus-therapeutics-to-attend-the-following-investor-conferences","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/arcturus-therapeutics-to-attend-the-following-investor-conferences\/","title":{"rendered":"Arcturus Therapeutics to Attend the Following Investor Conferences"},"content":{"rendered":"<div>\n<p>SAN DIEGO&#8211;(BUSINESS WIRE)&#8211;Arcturus Therapeutics Holdings Inc. (the \u201cCompany\u201d, \u201cArcturus\u201d, Nasdaq: ARCT), a global, late-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that the Company will participate in the following investor conferences.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220901005815\/en\/837248\/5\/arcturus-logo-blueback.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220901005815\/en\/837248\/21\/arcturus-logo-blueback.jpg\"><\/a><\/p>\n<p>\n<b>Citi\u2019s 17<sup>th<\/sup> Annual BioPharma Conference<\/b> (Attending)\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nTuesday \u2013 Thursday, September 6 \u2013 8, 2022\n<\/li>\n<\/ul>\n<p>\n<b>Wells Fargo Virtual Healthcare Conference<\/b> (Fireside Chat)\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nFriday, September 9, 2022 (8:35 a.m. ET)\n<\/li>\n<\/ul>\n<p>\n<b>H.C. Wainwright 24<sup>th<\/sup> Annual Global Investment Conference<\/b> (Presentation)\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nMonday, September 12, 2022 (3:00 p.m. ET)\n<\/li>\n<\/ul>\n<p>\n<b>Baird Global Healthcare Conference<\/b> (Presentation)\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nWednesday, September 14, 2022 (10:15 a.m. ET)\n<\/li>\n<\/ul>\n<p>\n<b>Cantor Global Healthcare Conference<\/b> (Panel Presentation)\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nThursday, September 15, 2022 (2:30 p.m. ET)\n<\/li>\n<\/ul>\n<p>\n<b>Piper Sandler Heartland Summit<\/b> (Attending)\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nWednesday \u2013 Thursday, September 21 \u2013 22, 2022\n<\/li>\n<\/ul>\n<p>\nLinks will be available under the Investor Relations\/Events section of Arcturus\u2019 <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fir.arcturusrx.com%2Finvestor-calendar&amp;esheet=52854863&amp;newsitemid=20220901005815&amp;lan=en-US&amp;anchor=website&amp;index=1&amp;md5=11fff4a9f39763c550e765c901c18a7c\" rel=\"nofollow noopener\" shape=\"rect\">website<\/a>.\n<\/p>\n<p>\n<b>About Arcturus Therapeutics<\/b>\n<\/p>\n<p>\nFounded in 2013 and based in San Diego, California, Arcturus Therapeutics Holdings Inc. (Nasdaq: ARCT) is a global, late-stage clinical mRNA medicines and vaccines company with enabling technologies: (i) LUNAR\u00ae lipid-mediated delivery, (ii) STARR\u2122 mRNA Technology (samRNA) and (iii) mRNA drug substance along with drug product manufacturing expertise. Arcturus\u2019 diverse pipeline of RNA therapeutic and vaccine candidates includes mRNA vaccine programs for SARS-CoV-2 (COVID-19) and Influenza, and other programs to potentially treat ornithine transcarbamylase (OTC) deficiency, and cystic fibrosis, along with partnered programs including glycogen storage disease type III, and hepatitis B virus. Arcturus\u2019 versatile RNA therapeutics platforms can be applied toward multiple types of nucleic acid medicines including messenger RNA, small interfering RNA, replicon RNA, antisense RNA, microRNA, DNA, and gene editing therapeutics. Arcturus\u2019 technologies are covered by its extensive patent portfolio (patents and patent applications issued in the U.S., Europe, Japan, China and other countries). Arcturus\u2019 commitment to the development of novel RNA therapeutics has led to collaborations including, amongst others, Janssen Pharmaceuticals, Inc., part of the Janssen Pharmaceutical Companies of Johnson &amp; Johnson, Ultragenyx Pharmaceutical, Inc., and the Cystic Fibrosis Foundation. In addition, please connect with us on <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2FArcturusRx&amp;esheet=52854863&amp;newsitemid=20220901005815&amp;lan=en-US&amp;anchor=Twitter&amp;index=2&amp;md5=01bd95964395a7941df413d43ef68e3e\" rel=\"nofollow noopener\" shape=\"rect\">Twitter<\/a> and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Farcturus-therapeutics&amp;esheet=52854863&amp;newsitemid=20220901005815&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=3&amp;md5=ff50599f5e7967367e3d83dd675ca3db\" rel=\"nofollow noopener\" shape=\"rect\">LinkedIn<\/a>. For more information visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.ArcturusRx.com&amp;esheet=52854863&amp;newsitemid=20220901005815&amp;lan=en-US&amp;anchor=www.ArcturusRx.com&amp;index=4&amp;md5=aed67832ff00e52690030f8fdf0979ad\" rel=\"nofollow noopener\" shape=\"rect\">www.ArcturusRx.com<\/a>.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>IR and Media Contacts<\/b><br \/>Arcturus Therapeutics<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#105;lt&#x6f;&#x3a;&#73;&#82;&#64;&#x61;&#x72;&#99;&#116;u&#x72;&#x75;&#x73;&#114;x&#46;&#x63;&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#73;&#x52;&#64;&#x61;&#114;&#x63;t&#x75;r&#117;&#x73;&#114;&#x78;&#46;&#x63;o&#x6d;<\/a>\n<\/p>\n<p>\nKendall Investor Relations<br \/>\n<br \/>Carlo Tanzi, Ph.D.<br \/>\n<br \/>(617) 914-0008<br \/>\n<br \/><a target=\"_blank\" href=\"ma&#105;&#108;&#116;&#111;&#x3a;&#x63;&#x74;&#x61;&#x6e;zi&#64;&#107;&#101;&#110;&#x64;&#x61;&#x6c;&#x6c;&#x69;r&#46;&#99;&#111;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">c&#116;&#97;&#x6e;&#x7a;i&#64;&#107;&#x65;&#x6e;&#x64;a&#108;&#108;&#x69;&#x72;&#46;c&#111;&#x6d;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO&#8211;(BUSINESS WIRE)&#8211;Arcturus Therapeutics Holdings Inc. (the \u201cCompany\u201d, \u201cArcturus\u201d, Nasdaq: ARCT), a global, late-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that the Company will participate in the following investor conferences. Citi\u2019s 17th Annual BioPharma Conference (Attending) Tuesday \u2013 &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/arcturus-therapeutics-to-attend-the-following-investor-conferences\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-47923","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Arcturus Therapeutics to Attend the Following Investor Conferences - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/arcturus-therapeutics-to-attend-the-following-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Arcturus Therapeutics to Attend the Following Investor Conferences - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO&#8211;(BUSINESS WIRE)&#8211;Arcturus Therapeutics Holdings Inc. (the \u201cCompany\u201d, \u201cArcturus\u201d, Nasdaq: ARCT), a global, late-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that the Company will participate in the following investor conferences. Citi\u2019s 17th Annual BioPharma Conference (Attending) Tuesday \u2013 ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/arcturus-therapeutics-to-attend-the-following-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-01T20:01:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220901005815\/en\/837248\/21\/arcturus-logo-blueback.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arcturus-therapeutics-to-attend-the-following-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arcturus-therapeutics-to-attend-the-following-investor-conferences\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Arcturus Therapeutics to Attend the Following Investor Conferences\",\"datePublished\":\"2022-09-01T20:01:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arcturus-therapeutics-to-attend-the-following-investor-conferences\\\/\"},\"wordCount\":360,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arcturus-therapeutics-to-attend-the-following-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220901005815\\\/en\\\/837248\\\/21\\\/arcturus-logo-blueback.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arcturus-therapeutics-to-attend-the-following-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arcturus-therapeutics-to-attend-the-following-investor-conferences\\\/\",\"name\":\"Arcturus Therapeutics to Attend the Following Investor Conferences - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arcturus-therapeutics-to-attend-the-following-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arcturus-therapeutics-to-attend-the-following-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220901005815\\\/en\\\/837248\\\/21\\\/arcturus-logo-blueback.jpg\",\"datePublished\":\"2022-09-01T20:01:39+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arcturus-therapeutics-to-attend-the-following-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arcturus-therapeutics-to-attend-the-following-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arcturus-therapeutics-to-attend-the-following-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220901005815\\\/en\\\/837248\\\/21\\\/arcturus-logo-blueback.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220901005815\\\/en\\\/837248\\\/21\\\/arcturus-logo-blueback.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arcturus-therapeutics-to-attend-the-following-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Arcturus Therapeutics to Attend the Following Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Arcturus Therapeutics to Attend the Following Investor Conferences - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/arcturus-therapeutics-to-attend-the-following-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Arcturus Therapeutics to Attend the Following Investor Conferences - Pharma Trend","og_description":"SAN DIEGO&#8211;(BUSINESS WIRE)&#8211;Arcturus Therapeutics Holdings Inc. (the \u201cCompany\u201d, \u201cArcturus\u201d, Nasdaq: ARCT), a global, late-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that the Company will participate in the following investor conferences. Citi\u2019s 17th Annual BioPharma Conference (Attending) Tuesday \u2013 ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/arcturus-therapeutics-to-attend-the-following-investor-conferences\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-01T20:01:39+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220901005815\/en\/837248\/21\/arcturus-logo-blueback.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/arcturus-therapeutics-to-attend-the-following-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/arcturus-therapeutics-to-attend-the-following-investor-conferences\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Arcturus Therapeutics to Attend the Following Investor Conferences","datePublished":"2022-09-01T20:01:39+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/arcturus-therapeutics-to-attend-the-following-investor-conferences\/"},"wordCount":360,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/arcturus-therapeutics-to-attend-the-following-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220901005815\/en\/837248\/21\/arcturus-logo-blueback.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/arcturus-therapeutics-to-attend-the-following-investor-conferences\/","url":"https:\/\/pharma-trend.com\/en\/arcturus-therapeutics-to-attend-the-following-investor-conferences\/","name":"Arcturus Therapeutics to Attend the Following Investor Conferences - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/arcturus-therapeutics-to-attend-the-following-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/arcturus-therapeutics-to-attend-the-following-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220901005815\/en\/837248\/21\/arcturus-logo-blueback.jpg","datePublished":"2022-09-01T20:01:39+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/arcturus-therapeutics-to-attend-the-following-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/arcturus-therapeutics-to-attend-the-following-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/arcturus-therapeutics-to-attend-the-following-investor-conferences\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220901005815\/en\/837248\/21\/arcturus-logo-blueback.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220901005815\/en\/837248\/21\/arcturus-logo-blueback.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/arcturus-therapeutics-to-attend-the-following-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Arcturus Therapeutics to Attend the Following Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47923","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47923"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47923\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47923"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47923"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47923"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}